pharma.be is the voice of the innovative Belgian - human and veterinary medicine - pharmaceutical industry. As interest group it represents 130 both small and large innovative pharmaceutical and biotech companies and is the centre of excellence for the industry. 

pharma.be’s member companies are a major contributor to the Belgian economy. They supply 80 percent of all medicines used in Belgium and have more than 42000 employees. pharma.be is recognised by the government as the association to negotiate on behalf of the innovative biopharmaceutical industry with the Minister of Health, the Minister of Economy, and national bodies such as the National Institute for Health and Disability Insurance (RIZIV/INAMI) and the Federal Agency for Medicines and Health Products (FAGG/AFMPS). 

Working at the heart of the policy development and decision-making, the aim of pharma.be is to ensure that patients can benefit from the latest and most advanced medicines. 

Program:

• 12h00-12h45: Lunch
• 12h45-13h30: How does pharma.be defend the interests of the innovative pharma industry in Belgium? by Herman Van Eeckhout, Political & Finance Director at pharma.be
• 13h30-13h45: Q&A and discussion

Please note a no-show fee of 50 € will be applied for every participant (also members).